↓ Skip to main content

Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden

Overview of attention for article published in European Heart Journal, June 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
149 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
Published in
European Heart Journal, June 2012
DOI 10.1093/eurheartj/ehs157
Pubmed ID
Authors

Thomas Davidson, Magnus Husberg, Magnus Janzon, Jonas Oldgren, Lars-Åke Levin

Abstract

Patients with atrial fibrillation have a significantly increased risk of thromboembolic events such as ischaemic stroke, and patients are therefore recommended to be treated with anticoagulation treatment. The most commonly used anticoagulant consists of vitamin K antagonist such as warfarin. A new oral anticoagulation treatment, dabigatran, has recently been approved for stroke prevention among patients with atrial fibrillation. The purpose of this study was to estimate the cost-effectiveness of dabigatran as preventive treatment of stroke and thromboembolic events compared with warfarin in 65-year-old patients with atrial fibrillation in Sweden.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 2 1%
Netherlands 1 <1%
Colombia 1 <1%
Slovenia 1 <1%
United States 1 <1%
Unknown 143 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 19%
Researcher 20 13%
Student > Bachelor 19 13%
Student > Ph. D. Student 16 11%
Student > Doctoral Student 7 5%
Other 22 15%
Unknown 36 24%
Readers by discipline Count As %
Medicine and Dentistry 66 44%
Pharmacology, Toxicology and Pharmaceutical Science 14 9%
Economics, Econometrics and Finance 11 7%
Agricultural and Biological Sciences 5 3%
Social Sciences 3 2%
Other 9 6%
Unknown 41 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#6,571,725
of 25,374,647 outputs
Outputs from European Heart Journal
#5,226
of 11,049 outputs
Outputs of similar age
#44,262
of 177,530 outputs
Outputs of similar age from European Heart Journal
#29
of 94 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 11,049 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.6. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.